Indication
Endometriosis-associated Pain
1 clinical trial
3 products
Product
BG2109Clinical trial
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of BG2109 in Chinese Subjects With EndometriosisStatus: Recruiting, Estimated PCD: 2024-06-01
Product
ABT(E2 1 mg / NETA 0.5 mg)Product
ABT